Singapore’s KPB Biosciences fails in bid to unfreeze assets in US$830 million Novo Nordisk legal battle
Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be frozen, ...
Tag: US830
Novo seeks US$830 million from Singapore firm, accusing it of fraud over drug
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying that it was misled ...
China to invest more than US$830 million in solid-state battery research
China plans to invest more than US$830 million in a government-led project to develop solid-state batteries with six firms eligible ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
NEWS
- Business
- Technology
- Entertainment
- Sports
- Lifestyle
- Health
- Politics
- Real Estate
© 2025 The New York Journals. All Rights Reserved.